Isolated sulfite oxidase deficiency

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:99731OMIM:272300E72.1
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Isolated sulfite oxidase deficiency (ISOD) is an extremely rare autosomal recessive metabolic disorder caused by mutations in the SUOX gene, which encodes the enzyme sulfite oxidase. This enzyme is essential for the final step in the degradation of sulfur-containing amino acids (methionine and cysteine), converting toxic sulfite to sulfate. When this enzyme is deficient, sulfite and other toxic metabolites (S-sulfocysteine, thiosulfate, taurine) accumulate in the body, causing severe damage primarily to the central nervous system. The disease predominantly presents in the neonatal period with intractable seizures, feeding difficulties, and progressive encephalopathy. Affected infants typically develop severe intellectual disability, spasticity, microcephaly, and characteristic lens dislocation (ectopia lentis). Brain imaging often reveals extensive white matter changes, cystic encephalomalacia, and cerebral atrophy. The clinical presentation closely resembles molybdenum cofactor deficiency, which also impairs sulfite oxidase activity but additionally affects xanthine dehydrogenase and aldehyde oxidase. The two conditions can be distinguished biochemically, as isolated sulfite oxidase deficiency shows elevated sulfite and S-sulfocysteine but normal uric acid and xanthine levels. A milder, late-onset form has been described in rare cases, presenting with developmental delay and movement abnormalities rather than the devastating neonatal course. Unfortunately, there is currently no effective cure or disease-modifying treatment for isolated sulfite oxidase deficiency. Management is primarily supportive, focusing on seizure control (which is often refractory to standard anticonvulsants), nutritional support, and physical therapy. Dietary restriction of methionine and cysteine has been attempted with limited success. The prognosis for the severe neonatal form is generally poor, with significant morbidity and early mortality.

Also known as:

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Isolated sulfite oxidase deficiency.

View clinical trials →

No actively recruiting trials found for Isolated sulfite oxidase deficiency at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Isolated sulfite oxidase deficiency community →

No specialists are currently listed for Isolated sulfite oxidase deficiency.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Isolated sulfite oxidase deficiency.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Isolated sulfite oxidase deficiencyForum →

No community posts yet. Be the first to share your experience with Isolated sulfite oxidase deficiency.

Start the conversation →

Latest news about Isolated sulfite oxidase deficiency

No recent news articles for Isolated sulfite oxidase deficiency.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Isolated sulfite oxidase deficiency

What is Isolated sulfite oxidase deficiency?

Isolated sulfite oxidase deficiency (ISOD) is an extremely rare autosomal recessive metabolic disorder caused by mutations in the SUOX gene, which encodes the enzyme sulfite oxidase. This enzyme is essential for the final step in the degradation of sulfur-containing amino acids (methionine and cysteine), converting toxic sulfite to sulfate. When this enzyme is deficient, sulfite and other toxic metabolites (S-sulfocysteine, thiosulfate, taurine) accumulate in the body, causing severe damage primarily to the central nervous system. The disease predominantly presents in the neonatal period with

How is Isolated sulfite oxidase deficiency inherited?

Isolated sulfite oxidase deficiency follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Isolated sulfite oxidase deficiency typically begin?

Typical onset of Isolated sulfite oxidase deficiency is neonatal. Age of onset can vary across affected individuals.